12 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 28389270 | Combination of valproic acid and morpholino splice-switching oligonucleotide produces improved outcomes in spinal muscular atrophy patient-derived fibroblasts. | 2017 Sep | 2 |
2 | 25042492 | [Effect of valproic acid on SMN protein level in peripheral blood mononuclear cells of patients with spinal muscular atrophy and different SMN2 copy numbers]. | 2014 | 1 |
3 | 25143843 | Valproate Treatment in an ALS Patient Carrying a c.194G>A Spastin Mutation and SMN2 Homozygous Deletion. | 2014 | 1 |
4 | 23077215 | VPA response in SMA is suppressed by the fatty acid translocase CD36. | 2013 Jan 15 | 4 |
5 | 21561730 | Valproic acid increases SMN2 expression and modulates SF2/ASF and hnRNPA1 expression in SMA fibroblast cell lines. | 2012 Mar | 6 |
6 | 21610752 | Treatment of spinal muscular atrophy cells with drugs that upregulate SMN expression reveals inter- and intra-patient variability. | 2011 Oct | 1 |
7 | 18025935 | Clinical trials in spinal muscular atrophy. | 2007 Dec | 1 |
8 | 16508748 | Mildly affected patients with spinal muscular atrophy are partially protected by an increased SMN2 copy number. | 2006 May | 1 |
9 | 16775228 | Valproate may improve strength and function in patients with type III/IV spinal muscle atrophy. | 2006 Aug 8 | 1 |
10 | 17027862 | Spinal muscular atrophy: from gene to therapy. | 2006 Jun | 2 |
11 | 17076267 | Spinal muscular atrophy and therapeutic prospects. | 2006 | 2 |
12 | 12915451 | Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy. | 2003 Oct 1 | 5 |